![Lior Teitelbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lior Teitelbaum
Directeur/Membre du Conseil chez
Protekt Therapeutics Ltd.
Profil
Lior Teitelbaum was the founder of MindUP Ltd., founded in 2016, and served as Vice President-Business Development from 2016 to 2018.
Current jobs include Board of Director at FutuRx Ltd. since 2019, Director at ProteKt Therapeutics Ltd. since 2019, Principal at Johnson & Johnson Innovation - JJDC, Inc. since 2022, and Board member at A2i Therapeutics Ltd. since 2021.
Former jobs include Senior Director-Business Development at BioLineRx Ltd. from 2015 to 2016, Director-Business Development & Marketing at Metacure Israel Ltd. from 2010 to 2012, and Board Member at Pg Medical Systems Ltd. from 2018 to 2019.
Education includes an undergraduate degree from The Hebrew University of Jerusalem in 2001, a graduate degree from Weizmann Institute of Science in 2004, and an MBA from Tel-Aviv University in 2009.
Postes actifs de Lior Teitelbaum
| Sociétés | Poste | Début |
|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | 01/02/2022 |
A2i Therapeutics Ltd.
 A2i Therapeutics Ltd. Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | 01/01/2021 |
Protekt Therapeutics Ltd.
 Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de Lior Teitelbaum
| Sociétés | Poste | Fin |
|---|---|---|
Pg Medical Systems Ltd.
 Pg Medical Systems Ltd. Information Technology ServicesTechnology Services Provides machine-learning pain management and telehealth services | Directeur/Membre du Conseil | 01/01/2019 |
MindUP Ltd.
 MindUP Ltd. Medical SpecialtiesHealth Technology Develops digital health incubators | Fondateur | 01/12/2018 |
| BIOLINERX LTD. | Private Equity Investor | 01/05/2015 |
Metacure Israel Ltd. | Sales & Marketing | 01/01/2012 |
Formation de Lior Teitelbaum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
 BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Metacure Israel Ltd. | |
Protekt Therapeutics Ltd.
Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MindUP Ltd.
MindUP Ltd. Medical SpecialtiesHealth Technology Develops digital health incubators | Health Technology |
Pg Medical Systems Ltd.
Pg Medical Systems Ltd. Information Technology ServicesTechnology Services Provides machine-learning pain management and telehealth services | Technology Services |
A2i Therapeutics Ltd.
A2i Therapeutics Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
